Drug: vancomycin Quarter: 2016Q3
Total Records: 1,050 Number of Pages: 53
| DRUGNAME | PT | EventCount |
|---|---|---|
| VANCOMYCIN INJECTION, USP | Plasma cell myeloma | 1 |
| VANCOMYCIN INJECTION, USP | Pulmonary oedema | 1 |
| VANCOMYCIN INJECTION, USP | Urticaria | 1 |
| VANCOMYCIN INJECTION, USP | Wound secretion | 1 |
| VANCOMYCIN KABI 1000mg | Acidosis | 1 |
| VANCOMYCIN KABI 1000mg | Acute kidney injury | 1 |
| VANCOMYCIN KABI 1000mg | Blister | 1 |
| VANCOMYCIN KABI 1000mg | Cardiovascular insufficiency | 1 |
| VANCOMYCIN KABI 1000mg | Dialysis | 1 |
| VANCOMYCIN KABI 1000mg | Endotracheal intubation | 1 |
| VANCOMYCIN KABI 1000mg | Fluid overload | 1 |
| VANCOMYCIN KABI 1000mg | Hepatic failure | 1 |
| VANCOMYCIN KABI 1000mg | Hypotension | 1 |
| VANCOMYCIN KABI 1000mg | Rash pruritic | 1 |
| VANCOMYCIN KABI 1000mg | Renal failure | 1 |
| VANCOMYCIN KABI 1000mg | Toxic epidermal necrolysis | 1 |
| VANCOMYCIN MYLAN | Bradycardia | 1 |
| Vancomycin Mylan | Drug chemical incompatibility | 1 |
| VANCOMYCIN MYLAN | Intentional product use issue | 1 |
| Vancomycin Mylan | Liquid product physical issue | 1 |
Total Records: 1,050 Number of Pages: 53